Home » Stocks » HIMS

Hims & Hers Health, Inc. (HIMS)

Stock Price: $9.78 USD -0.54 (-5.23%)
Updated May 11, 2021 9:59 AM EDT - Market open
Market Cap 2.07B
Revenue (ttm) 148.76M
Net Income (ttm) -18.11M
Shares Out 78.05M
EPS (ttm) -0.23
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 11
Last Price $9.78
Previous Close $10.32
Change ($) -0.54
Change (%) -5.23%
Day's Open 9.64
Day's Range 9.32 - 9.85
Day's Volume 540,711
52-Week Range 9.32 - 25.40

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today announced ...

6 days ago - Business Wire

Shares of Hims & Hers Health, Inc. (NYSE:HIMS) are in trouble. The stock is testing critical support and if this support holds, shares may rally.

3 weeks ago - Benzinga

Here are three companies with exciting growth stories that just went public.

Other stocks mentioned: BMBL, RBLX
3 weeks ago - The Motley Fool

These companies are at the forefront of innovation in the healthcare sector, and their stocks are surprisingly affordable too.

Other stocks mentioned: PFE, YI
1 month ago - The Motley Fool

Ignore the near-term pullback in Hims & Hers. With its unique business model, telehealth play HIMS stock remains a potential long-term winner.

1 month ago - InvestorPlace

Hims & Hers CEO on portfolio expansion opportunities, company outlook

YouTube video

Yahoo Finance's Brian Sozzi, Myles Udland, and Julie Hyman speak with Hims & Hers Co-founder & CEO Andrew Dudum about the company's first earnings report since going public.

1 month ago - Yahoo Finance

Shares of the newly public company dropped on weak guidance in its fourth-quarter earnings report.

1 month ago - The Motley Fool

There are a lot of crosscurrents in the market right now.

Other stocks mentioned: FDX
1 month ago - The Motley Fool

Multi-specialty telehealth platform Hims & Hers Health, Inc. reported that revenue surged 67 percent from the fourth quarter of 2019 to the fourth quarter of 2020. “This is an organization built on soli...

1 month ago - PYMNTS

Hims & Hers Health Inc. (NYSE: HIMS) reported its financial results for the fiscal fourth quarter on Thursday that came in better than what analysts had anticipated, despite the ongoing Coronavirus pand...

1 month ago - Invezz

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today reported f...

1 month ago - Business Wire

SAN FRANCISCO--(BUSINESS WIRE)--Andrea Perez and Ambar Bhattacharyya join Hims & Hers Board of Directors to help the company pioneer a better way for patients to access healthcare.

2 months ago - Business Wire

A small company by the name of Conversion Labs (NASDAQ:CVLB) will be the eBay or Alibaba of the DTC telemedicine platforms space. The post This DTC Telemedicine Stock Has Enormous Potential Thanks to th...

Other stocks mentioned: CVLB
2 months ago - InvestorPlace

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, will participate...

2 months ago - Business Wire

SPACs dominated Wall Street in 2020. The backwards IPOs of these three companies suggests that 2021 will be more of the same.

Other stocks mentioned: APPH, GMTX
2 months ago - InvestorPlace

Telehealth is the future, and Hims & Hers looks well-positioned for that future. Growth should keep the rally in HIMS stock going.

2 months ago - InvestorPlace

The prospects for HIMS stock look good. The company has certainly built a robust platform.

2 months ago - InvestorPlace

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, will release fis...

3 months ago - Business Wire

If you believe in the future of telemedicine, then keep an eye on HIMS stock. It might not be in the buy zone yet, though, so be patient.

3 months ago - InvestorPlace

The company has had early success in building a customer base as well as infrastructure to support their demand. HIMS offers frictionless patient to consumer experiences that are cost efficient and comp...

3 months ago - Seeking Alpha

With its focus on millennials, fast growing telemedicine play HIMS stock has plenty of room to run after its recent SPAC merger. The post Buy Hims & Hers Stock for a Solid Play on Telehealth appeared fi...

3 months ago - InvestorPlace

Hims & Hers CEO on $1.6 billion SPAC deal and goal to provide affordable health care

YouTube video

Hims & Hers Co-Founder and CEO Andrew Dudum joins Yahoo Finance's Brain Sozzi and Julie Hyman to discuss the company's $1.6 billion SPAC deal with Oaktree Capital Management and discuss the future of me...

3 months ago - Yahoo Finance

Hims & Hers, a San Francisco-based telehealth startup that sells sexual wellness and other health products and services to millennials, began trading publicly today on the NYSE after completing a revers...

Other stocks mentioned: OAC
3 months ago - TechCrunch

Telehealth play HIMS stock makes its debut today. Here's what you should know about newly public Hims & Hers now.

Other stocks mentioned: OAC
3 months ago - InvestorPlace

About HIMS

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's cu... [Read more...]

Industry
Household & Personal Products
Founded
2017
Stock Exchange
NYSE
Ticker Symbol
HIMS
Full Company Profile

Financial Performance

In 2020, HIMS's revenue was $148.76 million, an increase of 80.18% compared to the previous year's $82.56 million. Losses were -$18.11 million, -74.86% less than in 2019.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for HIMS is 16.50, which is an increase of 68.71% from the latest price.

Price Target
$16.50
(68.71% upside)